Fosun Pharmaceutical seeks $594 million from HK listing

Prudential agrees to buy $50 million worth of shares, bringing the total cornerstone investment to $75 million.
<div style="text-align: left;"> Back to work: Fosun is the first new listing in Hong Kong for three months </div>
<div style="text-align: left;"> Back to work: Fosun is the first new listing in Hong Kong for three months </div>
October 17, 2012

Shanghai Fosun Pharmaceutical Group yesterday kicked off the institutional roadshow and bookbuilding for the first Hong Kong listing in three months and the biggest since Yitai Coal raised $902 million in early July. As such, the deal will be extremely important as a gauge of investor appetite for Chinese companies.

The private sector company is seeking to raise between HK$3.97 billion and HK$4.6 billion $512 million to $594 million from the sale of 15% of its enlarged share capital.

The offering got an early boost after it emerged yesterday that Prudential, which is one of the two cornerstone investors, had decided to increase its investment...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222